Literature DB >> 19390951

Extremely acute exacerbation of interstitial pneumonia after interferon-alpha treatment for metastatic renal cell carcinoma.

Satoshi Ando1, Koji Kawai, Ken Kuriyagawa, Noritoshi Sekido, Naoto Miyanaga, Toru Shimazui, Hideyuki Akaza.   

Abstract

We report the case of a 62-year-old Japanese man who presented with right renal cell carcinoma and multiple metastases. The patient had a past medical history of idiopathic interstitial pneumonia 6 years previously. He had received pulse corticosteroid therapy and oral prednisolone, which resulted in marked clinical improvement. He had been followed up for the interstitial pneumonia, without medication, for 5 years and the idiopathic interstitial pneumonia was inactive when the metastatic renal cell carcinoma was diagnosed. However, the patient presented with extremely acute exacerbation of the interstitial pneumonia that occurred after only three intramuscular injections of standard-dose interferon-alpha. Urologists should be aware of this complication in the treatment of renal cell carcinoma patients who have a prior history of interstitial pneumonia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19390951     DOI: 10.1007/s10147-008-0817-8

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  5 in total

Review 1.  Acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Robert Hyzy; Steven Huang; Jeffrey Myers; Kevin Flaherty; Fernando Martinez
Journal:  Chest       Date:  2007-11       Impact factor: 9.410

2.  Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C.

Authors:  M Shindo; A M Di Bisceglie; J H Hoofnagle
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

3.  High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-alpha.

Authors:  J L Steegmann; M J Requena; P Martín-Regueira; R De La Cámara; F Casado; F Rodriguez Salvanés; J M Fernández Rañada
Journal:  Am J Hematol       Date:  2003-03       Impact factor: 10.047

Review 4.  Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature.

Authors:  John Midturi; Miguel Sierra-Hoffman; Douglas Hurley; Richard Winn; Robert Beissner; John Carpenter
Journal:  Clin Infect Dis       Date:  2004-11-08       Impact factor: 9.079

5.  Circulating KL-6 level at baseline is a predictive indicator for the occurrence of interstitial pneumonia during interferon treatment for chronic hepatitis C.

Authors:  Hajime Tokita; Hideo Fukui; Akihisa Tanaka; Hiroshi Kamitsukasa; Michiyasu Yagura; Hideharu Harada; Akira Hebisawa; Atsuyuki Kurashima; Hiroaki Okamoto
Journal:  Hepatol Res       Date:  2003-06       Impact factor: 4.288

  5 in total
  1 in total

Review 1.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.